MoneyWorks4Me

Lupin - Quaterly Results

09 May 2023 Evaluate
Revenue showed a marginal decline at Rs. 28362.70 millions. For the quarter ended March 2023, as compared to corresponding quarter of last year.The Total Profit for the quarter ended March 2023 of Rs. 1190.10 millions grew from Rs.-358.90 millionsOperating profit for the quarter ended March 2023 decreased to 3174.80 millions as compared to 5171.50 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 28362.70 28553.90 -0.67 112588.30 117716.70 -4.36 112588.30 117716.70 -4.36
Other Income 553.00 161.50 242.41 912.60 1504.20 -39.33 912.60 1504.20 -39.33
PBIDT 3174.80 5171.50 -38.61 11739.20 4261.30 175.48 11739.20 4261.30 175.48
Interest 294.40 245.80 19.77 984.40 734.70 33.99 984.40 734.70 33.99
PBDT 2880.40 4925.70 -41.52 10754.80 3526.60 204.96 10754.80 3526.60 204.96
Depreciation 1462.00 1310.20 11.59 5483.40 5141.90 6.64 5483.40 5141.90 6.64
PBT 1418.40 3615.50 -60.77 5271.40 -1615.30 -426.34 5271.40 -1615.30 -426.34
TAX 228.30 3974.40 -94.26 1019.30 271.70 275.16 1019.30 271.70 275.16
Deferred Tax -25.90 3419.40 -100.76 60.40 -306.30 -119.72 60.40 -306.30 -119.72
PAT 1190.10 -358.90 -431.60 4252.10 -1887.00 -325.34 4252.10 -1887.00 -325.34
Equity 910.00 909.00 0.11 910.00 909.00 0.11 910.00 909.00 0.11
PBIDTM(%) 11.19 18.11 -38.20 10.43 3.62 188.03 10.43 3.62 188.03
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..